Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Wu

Showing results (1-10 of 156) with videos related to

Pageof 16
Sort By:
Austin Journal of Clinical Immunology|December 9, 2014
NKG2D Ligands in Cancer Immunotherapy: Target or Not?Jennifer Wu
BMJ Oncology|April 8, 2025
Souped-up natural killer (NK) cells for treating tough cancersJennifer Wu
Oncoimmunology|May 4, 2016
Antibody targeting soluble NKG2D ligand sMIC refuels and invigorates the endogenous immune system to fight cancerJennifer Wu
Critical Reviews in Immunology|August 4, 2021
Could Harnessing Natural Killer Cell Activity Be a Promising Therapy for Prostate Cancer?Jennifer Wu
Journal of Molecular and Genetic Medicine : an International Journal of Biomedical Research|March 4, 2014
IL-15 Agonists: The Cancer Cure CytokineJennifer Wu
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 3, 2024
Emerging Innate Immune Cells in Cancer Immunotherapy: Promises and ChallengesJennifer Wu
Hepatitis Monthly|December 13, 2012
Hepatitis B- and hepatitis C-related hepatocellular carcinomas in the United States: similarities and differencesJennifer Ng, Jennifer Wu
Chinese Clinical Oncology|November 6, 2018
Systemic therapy for hepatocellular carcinoma: beyond sorafenibPatrick Boland, Jennifer Wu
Cancer Metastasis Reviews|January 14, 2014
Insulin-like growth factor receptor-1 (IGF-IR) as a target for prostate cancer therapyJennifer Wu, Evan Yu
World Journal of Gastroenterology|November 18, 2015
Hypoxia inducible factor in hepatocellular carcinoma: A therapeutic targetDaniel Lin, Jennifer Wu
Pageof 16

Showing results (1-10 of 156) with videos related to

Sort By:
Pageof 16
Austin Journal of Clinical Immunology|December 9, 2014
NKG2D Ligands in Cancer Immunotherapy: Target or Not?Jennifer Wu
BMJ Oncology|April 8, 2025
Souped-up natural killer (NK) cells for treating tough cancersJennifer Wu
Oncoimmunology|May 4, 2016
Antibody targeting soluble NKG2D ligand sMIC refuels and invigorates the endogenous immune system to fight cancerJennifer Wu
Critical Reviews in Immunology|August 4, 2021
Could Harnessing Natural Killer Cell Activity Be a Promising Therapy for Prostate Cancer?Jennifer Wu
Journal of Molecular and Genetic Medicine : an International Journal of Biomedical Research|March 4, 2014
IL-15 Agonists: The Cancer Cure CytokineJennifer Wu
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 3, 2024
Emerging Innate Immune Cells in Cancer Immunotherapy: Promises and ChallengesJennifer Wu
Hepatitis Monthly|December 13, 2012
Hepatitis B- and hepatitis C-related hepatocellular carcinomas in the United States: similarities and differencesJennifer Ng, Jennifer Wu
Chinese Clinical Oncology|November 6, 2018
Systemic therapy for hepatocellular carcinoma: beyond sorafenibPatrick Boland, Jennifer Wu
Cancer Metastasis Reviews|January 14, 2014
Insulin-like growth factor receptor-1 (IGF-IR) as a target for prostate cancer therapyJennifer Wu, Evan Yu
World Journal of Gastroenterology|November 18, 2015
Hypoxia inducible factor in hepatocellular carcinoma: A therapeutic targetDaniel Lin, Jennifer Wu
Pageof 16